Technical Analysis for ETON - Eton Pharmaceutcials, Inc.

Grade Last Price % Change Price Change
grade F 6.65 0.00% 0.00
ETON closed unchanged on Thursday, July 18, 2019, on 60 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Earnings due: Aug 8

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A Down Down
See historical ETON trend table...

Date Alert Name Type % Chg
Calm After Storm Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Oversold Stochastic Weakness 0.00%
Stochastic Reached Oversold Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Down 5 Days in a Row Weakness 0.00%
Oversold Stochastic Weakness 0.00%

Older signals for ETON ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical product using the U.S. Food and Drug Administration's 505(b)(2) regulatory pathway. It primarily focuses on liquid products, including injectable, oral liquid, and ophthalmic products. The company is developing DS-300, an injectable nutrition product candidate; EM-100, an ophthalmic product for the treatment of allergic conjunctivitis; ET-103, an oral liquid product candidate; DS-100, an injectable product candidate for use in pain management; DS-200, an injectable parenteral nutrition product candidate; ET-101, an oral liquid product for use in seizure control; ET-102, an oral liquid product for use as a muscle relaxant; and CT-100, a synthetic corticotropin therapeutic candidate that mimics the amino acid chain of H.P. Acthar Gel. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.
Medicine Health Pharmaceutical Pain Pharmaceutical Industry In China Pharmaceuticals Policy Pain Management Science And Technology In The People's Republic Of China Ophthalmic Products Allergic Conjunctivitis Liquid Products Parenteral Nutrition Pharmaceutical Product
Is ETON a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 10.2
52 Week Low 5.7
Average Volume 73,416
200-Day Moving Average 0.0
50-Day Moving Average 7.8024
20-Day Moving Average 7.5751
10-Day Moving Average 7.6773
Average True Range 0.5269
ADX 19.03
+DI 17.6003
-DI 25.7489
Chandelier Exit (Long, 3 ATRs ) 7.4893
Chandelier Exit (Short, 3 ATRs ) 8.1407
Upper Bollinger Band 8.7104
Lower Bollinger Band 6.4398
Percent B (%b) 0.09
BandWidth 29.974522
MACD Line -0.169
MACD Signal Line -0.0342
MACD Histogram -0.1348
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 6.98
Resistance 3 (R3) 6.99 6.89 6.93
Resistance 2 (R2) 6.89 6.81 6.89 6.91
Resistance 1 (R1) 6.77 6.75 6.76 6.76 6.89
Pivot Point 6.67 6.67 6.67 6.67 6.67
Support 1 (S1) 6.55 6.59 6.54 6.54 6.41
Support 2 (S2) 6.45 6.53 6.45 6.39
Support 3 (S3) 6.33 6.45 6.38
Support 4 (S4) 6.32